Corporate Breakfast Symposium: Histotripsy in Practice: Real-World Experience, Evidence, and Future Frontiers (Presented by HistoSonics)

Tuesday, April 14, 2026

7:45 AM - 8:30 AM ET

Location: 718B

Presenter(s)

MS

Mikhail Silk, MD

Assistant Attending
Memorial Sloan Kettering Cancer Center, New York, United States
Jordan Tasse, MD

Associate professor of interventional radiology/Director of interventional oncology
Rush University Medical Center, Illinois, United States
Paul F. Laeseke, MD, PhD (he/him/his)

Associate Professor
University of Wisconsin, Wisconsin, United States
KB

Kevin Burns, MD

Director of Interventional Radiology
Providence Mission Hospital, California, United States

Histotripsy is transitioning from innovation to implementation. This symposium will explore real-world multidisciplinary use cases, lessons learned from early clinical experience, and best practices for integration into interventional oncology programs. Faculty will also review recent clinical research and publications, highlight ongoing studies, and share insights into future development plans and anticipated clinical expansion.

Learning Objectives:

Describe current real-world applications of histotripsy in oncology practice.
Identify best-practice considerations for patient selection, treatment planning, and multidisciplinary coordination.
Summarize key clinical research findings and recent publications related to histotripsy.
Discuss future clinical trials, emerging indications, and the potential impact of histotripsy on oncology care pathways.